No Data
ClouDr Group Limited to Discuss New Share Scheme
ClouDr Group Limited Names New Executive Director
Zhiyun Health (09955.HK) appointed Zuo Yinghui as an executive director.
December 4th, Geelong Hui announced that Zuo Yinghui has been appointed as an executive director of the company, effective from December 4, 2024.
Express News | ClouDr Group Ltd - Zuo Yinghui Appointed as an Executive Director
Hong Kong stocks are moving | Medical device stocks are collectively strengthening as product procurement rapidly warms up. Institutions indicate that a large number of order exchanges for old products is expected in the fourth quarter.
Medical device stocks rose collectively. As of the time of writing, Xin Tai Medical (02291) increased by 32.11%, trading at 22.3 HKD; MicroPort Robotics-B (02252) rose by 6.37%, trading at 9.19 HKD; Jian Shi Technology-B (09877) rose by 4.93%, trading at 3.19 HKD; Zhi Yun Health (09955) increased by 4.24%, trading at 1.23 HKD.
China Merchants Securities: The "AI + Healthcare" TOC application is beneficial to the public, and leading enterprises are expected to benefit first.
The introduction of AI is expected to improve data accuracy and continuity (asia vets wearable devices for continuous data collection, in conjunction with patient hospital medical records), provide professional personalized health services (AI doctors/nurses), and create more possibilities (brain-computer interfaces offer assistance in movement and neurological rehabilitation, improving the quality of life for people with disabilities, etc.).
